A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Launched by PFIZER · Aug 20, 2010
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older with diagnosis of plaque-type psoriasis (psoriasis vulgaris) for at least 12 months prior to first dose of study drug;
- • Psoriasis Area and Severity Index (PASI) score of 12 or greater, AND Physician's Global Assessment (PGA) score of 3 (moderate) or 4 (severe); Psoriasis covering at least 10% of body surface area;
- • No evidence of active or latent or inadequately treated infection with Tuberculosis or other serious infections.
- Exclusion Criteria:
- • Non-plaque or drug induced forms of psoriasis;
- • Cannot discontinue current oral, injectable or topical therapy for psoriasis or cannot discontinue phototherapy (Psoralen Ultraviolet A; Ultraviolet B).
- • Any uncontrolled significant medical condition.
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Providence, Rhode Island, United States
Winston Salem, North Carolina, United States
Cincinnati, Ohio, United States
Springfield, Illinois, United States
Fridley, Minnesota, United States
Fresno, California, United States
Berlin, New Jersey, United States
Trumbull, Connecticut, United States
South Miami, Florida, United States
Cleveland, Ohio, United States
Hamilton, Ontario, Canada
Nashville, Tennessee, United States
High Point, North Carolina, United States
Springfield, Illinois, United States
Los Angeles, California, United States
Hellerup, , Denmark
Clarksburg, West Virginia, United States
Malvern East, Victoria, Australia
Orange Park, Florida, United States
Webster, Texas, United States
Vancouver, British Columbia, Canada
Montreal, Quebec, Canada
Miami, Florida, United States
Portland, Oregon, United States
Arlington Heights, Illinois, United States
Wilmington, North Carolina, United States
Windsor, Ontario, Canada
Greer, South Carolina, United States
Miami, Florida, United States
Louisville, Kentucky, United States
Evansville, Indiana, United States
Quebec, , Canada
Mobile, Alabama, United States
Haverhill, Massachusetts, United States
St. John's, Newfoundland And Labrador, Canada
Ormond Beach, Florida, United States
San Francisco, California, United States
Cincinnati, Ohio, United States
Trnava, , Slovakia
Winston Salem, North Carolina, United States
Longmont, Colorado, United States
Oceanside, California, United States
Manchester, , United Kingdom
Tucson, Arizona, United States
Wilmington, North Carolina, United States
Saint John's, Newfoundland And Labrador, Canada
Wilmington, North Carolina, United States
Winston Salem, North Carolina, United States
Greer, South Carolina, United States
Malvern, Victoria, Australia
Svendborg, , Denmark
Nuneaton, Warwickshire, United Kingdom
Fremont, California, United States
Los Angeles, California, United States
Louisville, Kentucky, United States
Louisville, Kentucky, United States
Beverly, Massachusetts, United States
Clinton Township, Michigan, United States
Wilmington, North Carolina, United States
Charleston, South Carolina, United States
Charleston, South Carolina, United States
Charleston, South Carolina, United States
San Antonio, Texas, United States
Ciudad Autonoma De Buenos Aires, C1114aap, Argentina
Ciudad Autonoma De Buenos Aires, , Argentina
Kogarah, New South Wales, Australia
Kogarah, New South Wales, Australia
Carlton, Victoria, Australia
Carlton, Victoria, Australia
Rio De Janeiro, Rj, Brazil
Sao Paulo, Sp, Brazil
Pleven, , Bulgaria
Sofia, , Bulgaria
Sofia, , Bulgaria
Sofia, , Bulgaria
Sofia, , Bulgaria
Vancouver, British Columbia, Canada
Aarhus C, , Denmark
Tampere, , Finland
Aathens, , Greece
Ioannina, , Greece
Thessaloniki, , Greece
Beek, , Netherlands
Bratislava, , Slovakia
London, Leytonstone, United Kingdom
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials